BIRC5 and chronic myelogenous leukemia, BCR-ABL1 positive: It was reported that inhibitors of the NFκB pathway, such as the natural compounds triptolide [206] and berbamine [207], have been shown to induce apoptosis in CML imatinib-resistant cells by down-regulating survivin levels.